David Fisher

Executive Chairman David Fisher sells 28,500 ENVA shares ($6.6M) via scheduled 10b5-1 plan; retains 306,444 non-derivative shares plus 380,858 options

David Fisher executed 2 separate scheduled sales totaling 28,500 shares for $6,597,325.02 at a blended average price of $231.49 under a pre-arranged 10b5-1 trading plan, reducing his non-derivative holding from 334,944 to 306,444 shares. This represents a reduction of 8.5% of pre-transaction non-derivative holdings, though Fisher retains 380,858 derivative shares (Non-Qualified Stock Options) that constitute his material remaining position at the company. The sales occurred against a backdrop of strong recent momentum—the stock has advanced 21.5% over 30 days and 44.7% over 90 days—and solid fundamentals including $875.1M quarterly revenue, $91.1M net income, and 18.6% annual revenue growth. As a scheduled transaction under 10b5-1, the timing was predetermined rather than discretionary, and Fisher's cross-ticker track record shows 20 prior sells with an average 90-day return of 6.7%, while his ENVA-specific prior 4 measurable sales have posted mixed results ranging from -9.7% to +27.8% over 30 days.

ENVA: David Fisher (Executive Chairman) sold 33,060 shares at $199.05 under 10b5-1 plan; $6.6M transaction

David Fisher, Executive Chairman of Enova International, sold 33,060 shares (33.1K shares) for $6,580,639.28 ($6.6M) on 2026-06-17 as part of a pre-arranged 10b5-1 trading plan, leaving him with 306,444 non-derivative shares and 213,182 option holdings. The sale reduced his non-derivative holdings by 9.7% but occurred when the stock was at $199.05, near its 52-week high of $206.19 (-0.7%) and up +30.0% over 30 days and +49.0% over 90 days. His prior five trades at ENVA show mixed near-term results: two recent sells (2026-05-22 and 2026-05-21) were followed by +27.8% and +26.3% 30-day gains respectively, while earlier sells returned negative 30-day results, though longer-term outcomes at this ticker have been measurable in only two instances (one showing +7.5% 90-day gain, one showing +2.5%). Because this is a scheduled 10b5-1 transaction, the timing reflects plan mechanics rather than discretionary judgment; the stock's proximity to its 52-week high and strong recent momentum provide context but do not alter the nature of the trade as pre-arranged.

ENVA: Exec Chairman Fisher sells 10,256 shares for $1.6M via scheduled 10b5-1 plan

David Fisher, Executive Chairman of Enova International, Inc., executed 2 separate sales totaling 10,256 shares for $1,638,855.88 at blended average price $159.79 on May 21–22, 2026, pursuant to a pre-arranged 10b5-1 trading plan. This represents a scheduled transaction, not a discretionary decision. Post-transaction, Fisher holds 306,444 shares in non-derivative form, alongside derivative holdings of 249,318 shares (Non-Qualified Stock Option with limited SAR) and 246,242 shares (Non-Qualified Stock Option with limited SAR), indicating a substantial ongoing position in the company. At $159.05 current price, the stock is -10.0% from its 52-week high of $176.68 and -4.6% over the trailing 30 days, while ENVA's fundamentals remain solid: revenue of $875,142,000.00, net income of $91,099,000.00, annual revenue growth of +18.6%, and a P/E of 12.12. The transaction's scheduled nature and Fisher's retention of meaningful derivative and direct holdings provide limited insight into management conviction regarding near-term valuation.

Executive Chairman David Fisher sells 20,000 ENVA shares for $3.5M; repeat seller with mixed timing on prior exits at this stock.

Executive Chairman David Fisher sold a significant block of Enova shares on 2026-05-07, reducing his holdings by over 6 percent. This is Fisher's 32nd open-market sale in the past three years—he has never purchased shares on the open market, establishing a pure seller profile throughout his tenure. At the 30-day horizon, Fisher's prior five exits at this stock show strong timing, with four of those sales preceding price declines; however, over a 90-day window the pattern reverses, with only one of those five prior sales proving well-timed and the other four followed by gains Fisher missed. This conflicting short-term vs. long-term timing record makes it difficult to read conviction from the current sale. Enova itself is financially healthy—a profitable company with growing revenues and a reasonable valuation—so this transaction appears to be portfolio management rather than a distress sale. The stock currently trades at its 52-week high, which is an unusually strong price point for an insider seller; most insider selling occurs during weakness.

Executive Chairman Fisher David sold 7,143 ENVA shares at $149.49 for $1.1M on 2026-02-18; retains 326.4K shares.

Fisher David, Executive Chairman of Enova International (ENVA), sold 7,143 shares at $149.49 on 2026-02-18, reducing his holdings by -2.1% while retaining 326.4K shares post-transaction. The sale occurred during a period of recent weakness: the stock is down 8.1% over the past 30 days and -15.7% from its 52-week high of $172.37, though it is up 17.0% over 90 days. At ENVA specifically, Fisher's prior two sales (on 2026-01-30 and 2026-01-26) outcomes are not yet measurable, while his earlier ENVA sales showed mixed results—the 2025-10-27 sale followed by 28.5% 90-day appreciation and the 2025-11-21 sale followed by 16.7% 90-day appreciation. His cross-ticker track record across 20 prior sales shows an average 90-day return of +9.0% with a well-timed rate of 35.29%, indicating his sells have historically missed gains more often than they have preceded declines. The underlying business remains solid with a P/E of 9.27, 18.6% annual revenue growth, and 80.3M in net income on 802.7M revenue.

Executive Chairman David Fisher sold 37,989 shares of ENVA at $165.32 on 2026-01-30 for $6,280,151.54; holds 348,223 shares post-sale.

David Fisher, Executive Chairman of Enova International, sold 37,989 shares (9.8% of pre-transaction holdings) at $165.32 on 2026-01-30 for $6,280,151.54. The sale occurred near the stock's 52-week high of $172.37, with the current price at $159.07 showing -7.7% from that peak and +24.3% over 90 days. At the same-ticker level, Fisher's 5 prior ENVA trades show 0 of 2 measurable 90-day outcomes were well-timed (both prior completed trades showed positive 90-day returns of +28.5% and +30.5%, meaning the stock rose after his sales). His cross-ticker track record across 20 prior sells shows an average 90-day return of +9.4%, indicating a pattern where stocks have typically risen following his sales, with a well-timed rate of 35.29%. The company's fundamentals show strong performance: annual revenue growth of +25.5%, P/E of 13.46, and latest quarterly net income of $80.3M on $802.7M revenue, suggesting an established profitable business. The sale represents a discretionary reduction in his already substantial remaining stake of 348.2K shares.

Executive Chairman Fisher David sold 9,573 ENVA shares at $157.80 for $1,510,667.27; holds 348,223 post-sale amid 90d +33.6% rally.

Fisher David sold 9,573 shares of ENVA at $157.80 on 2026-01-26, reducing his holdings by 2.7% to 348,223 shares. The sale occurred during a strong 90-day rally of +33.6%, and the stock now trades at $159.26, just 3.4% below its 52-week high of $164.85. His prior trades at ENVA show a consistent pattern of poor timing at the 90-day horizon: 0 of 3 prior measurable sells were well-timed (all three showed positive 90-day returns, meaning the stock rose after he sold). His cross-ticker history fares only slightly better, with a 33.33% well-timed rate on 20 prior sells at other tickers. Given strong fundamentals (annual revenue growth +25.5%, P/E of 13.47, $802.7M quarterly revenue), the sale appears modest in scale and does not signify major repositioning at a fundamental level.

CEO Fisher David sold 15,000 ENVA shares at $160.24; stock now at $164.31 after 37.5% rally in 30 days.

Fisher David, Chief Executive Officer of Enova International, sold 15,000 shares on 2025-12-16 at $160.24, reducing his holdings from 363,223 to 348,223 shares. The sale occurred near the 52-week high of $164.31, with the stock having rallied 37.5% over the preceding 30 days and 30.4% over 90 days. His prior five trades at ENVA show a timing pattern of 0 of 3 measurable 90-day outcomes meeting well-timed thresholds, with only one 90-day gain (+30.5%) and two showing positive returns after sells at this ticker. The company's fundamentals remain solid: $802.7M in latest quarterly revenue, +25.5% annual growth, and a 13.9 P/E multiple, suggesting the sale occurs in a context of favorable valuation and business momentum rather than deteriorating operational conditions. The transaction is quantitatively modest relative to his remaining position (4.1% reduction) and does not constitute a concentrated liquidation.

CEO Fisher sells 6,000 ENVA shares at $124.25; stock now at $130.38, post-sale holdings 348.2K

Fisher David, CEO, sold 6,000 shares (6.0K shares) of ENVA at $124.25 on 2025-11-21, reducing holdings from 354.2K to 348.2K shares. The stock has since appreciated to $130.38 (current price), placing the sale price 4.6% below the current level. His prior trades at ENVA show a pattern of sales: five recent sells across 2025, with the two most recent showing 30-day declines of -13.5% and -13.3%, though outcomes beyond 30 days remain unmeasurable. His cross-ticker track record across 20 prior sales shows an average 90-day return of +9.3%, indicating his sells have historically been poorly timed (stock typically rose afterward). This sale does not materially alter his substantial remaining stake in the company.

CEO Fisher David sold 6,000 ENVA shares at $122.61 on 2025-10-27 (total $735.7K). Retains 348.2K shares; stock at $121.38.

Fisher David, Chief Executive Officer, sold 6,000 shares representing 1.7% of pre-transaction holdings at $122.61 per share, in a company with strong fundamentals: $802.7M quarterly revenue, $80.3M net income, and 25.5% annual revenue growth at a P/E of 10.27. His prior five sales at ENVA (conducted between 2025-08-28 and 2025-09-19) followed mixed patterns—three generated negative 30-day returns ranging from -13.5% to -7.1%, while two showed near-flat 30-day outcomes. His cross-ticker track record shows 42.86% of prior sales have been well-timed (negative 90-day return), with an average 90-day return of +10.3% after sells, indicating his sales historically have not been materially prescient. Current stock price of $121.38 sits 4.7% below the 52-week high of $127.32 and declined 0.5% in the 30-day period preceding the filing, though it gained 16.1% over 90 days—representing a window where the insider sold into a recently strengthened position.